Clinical trial
Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
NCT05980403 is registered in ClinicalTrials.gov with Yongshun Chen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of Lymph Node Status in Stage T1 Esophageal Squamous Cell Carcinoma（RENMIN-237）
- Lead sponsor
- Yongshun Chen
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 18, 2023
- Completion date
- December 18, 2024
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.